HMGCR and myositis disease: Serological testing in MAD-deficient cases, where available, showed antinuclear antibodies in 3/16, myositis-specific-antibodies in 1/9 (anti-MDA-5), anti-HMGCR in 2/6, and 0/16 cases had antibodies to extractable nuclear antigens.